Vanguard Global Advisers »

Kailera Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $384k 17k 22.03

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Rbc Cad (RY)

View all positions for Vanguard Global Advisers

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics